The Pharma Legal Handbook: Indonesia

Indonesia is Southeast Asia's largest pharmaceutical market and one of the fastest-growing in the Asia Pacific region. The National Agency of Drug and Food Control (BPOM) manages product registration and post-market surveillance, while the Ministry of Health oversees pricing and the national health insurance system (JKN), which has become a major commercial channel since its launch.

Indonesia has specific requirements around local manufacturing and local partner arrangements that international companies need to understand as part of their market entry strategy. The halal certification requirements for pharmaceutical products are also a distinctive feature of the Indonesian market that regulatory teams need to navigate.

The Pharma Legal Handbook: Indonesia provides comprehensive guidance on pharmaceutical regulation in Indonesia, covering BPOM product registration, JKN pricing and procurement, halal certification requirements, clinical trial requirements, pharmacovigilance obligations, manufacturing standards, marketing rules, and intellectual property protection.